A.J. Rice
Stock Analyst at UBS
(4.14)
# 508
Out of 4,984 analysts
242
Total ratings
61.49%
Success rate
9.64%
Average return
Main Sectors:
Stocks Rated by A.J. Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Initiates: Buy | $17 | $12.87 | +32.09% | 1 | Sep 10, 2025 | |
| ELV Elevance Health | Maintains: Buy | $435 → $425 | $310.00 | +37.10% | 5 | Sep 5, 2025 | |
| ENSG The Ensign Group | Maintains: Buy | $195 → $205 | $164.34 | +24.74% | 3 | Sep 2, 2025 | |
| ADUS Addus HomeCare | Initiates: Buy | $145 | $108.35 | +33.83% | 1 | Sep 2, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Neutral | $6.75 → $8 | $8.23 | -2.79% | 10 | Aug 19, 2025 | |
| MD Pediatrix Medical Group | Maintains: Neutral | $16 → $17 | $16.13 | +2.29% | 18 | Aug 14, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $10 → $8.5 | $7.60 | +11.84% | 3 | Aug 8, 2025 | |
| SEM Select Medical Holdings | Maintains: Neutral | $15 → $14 | $12.13 | +15.42% | 8 | Aug 4, 2025 | |
| CNC Centene | Maintains: Neutral | $45 → $31 | $31.80 | -2.52% | 19 | Jul 28, 2025 | |
| CYH Community Health Systems | Maintains: Neutral | $3.5 → $3.2 | $2.89 | +10.73% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $238 | $182.82 | +30.18% | 11 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $17 | $12.88 | +28.11% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $26 | $18.49 | +37.91% | 10 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $68 | $78.93 | -13.85% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $88 | $79.82 | +10.25% | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $40 | $27.56 | +45.14% | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $15 | $15.62 | -3.97% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $30 | $27.10 | +10.70% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $21.56 | +76.25% | 1 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $10.87 | +359.98% | 1 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $247 → $267 | $186.26 | +43.35% | 16 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $450 → $485 | $693.45 | -30.06% | 1 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $95 | $21.71 | +337.59% | 13 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $311 → $316 | $399.75 | -20.95% | 12 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $96 | $73.48 | +30.65% | 6 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $73 | $123.81 | -41.04% | 8 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $635 → $575 | $272.32 | +111.15% | 9 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $38 | $26.38 | +44.05% | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $590 → $610 | $339.78 | +79.53% | 12 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $308 → $305 | $274.09 | +11.28% | 4 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $64 → $79 | $148.37 | -46.75% | 3 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $350 → $410 | $176.45 | +132.36% | 3 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $43 → $37 | $4.96 | +645.97% | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $158 → $143 | $180.16 | -20.63% | 9 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $270 | $294.21 | -8.23% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $0.57 | $28.60 | -98.01% | 3 | Jan 25, 2021 |
Ardent Health
Sep 10, 2025
Initiates: Buy
Price Target: $17
Current: $12.87
Upside: +32.09%
Elevance Health
Sep 5, 2025
Maintains: Buy
Price Target: $435 → $425
Current: $310.00
Upside: +37.10%
The Ensign Group
Sep 2, 2025
Maintains: Buy
Price Target: $195 → $205
Current: $164.34
Upside: +24.74%
Addus HomeCare
Sep 2, 2025
Initiates: Buy
Price Target: $145
Current: $108.35
Upside: +33.83%
Aveanna Healthcare Holdings
Aug 19, 2025
Upgrades: Neutral
Price Target: $6.75 → $8
Current: $8.23
Upside: -2.79%
Pediatrix Medical Group
Aug 14, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $16.13
Upside: +2.29%
Enhabit
Aug 8, 2025
Maintains: Neutral
Price Target: $10 → $8.5
Current: $7.60
Upside: +11.84%
Select Medical Holdings
Aug 4, 2025
Maintains: Neutral
Price Target: $15 → $14
Current: $12.13
Upside: +15.42%
Centene
Jul 28, 2025
Maintains: Neutral
Price Target: $45 → $31
Current: $31.80
Upside: -2.52%
Community Health Systems
Jul 25, 2025
Maintains: Neutral
Price Target: $3.5 → $3.2
Current: $2.89
Upside: +10.73%
Jul 23, 2025
Maintains: Buy
Price Target: $230 → $238
Current: $182.82
Upside: +30.18%
May 13, 2025
Maintains: Neutral
Price Target: $19 → $17
Current: $12.88
Upside: +28.11%
May 13, 2025
Maintains: Neutral
Price Target: $30 → $26
Current: $18.49
Upside: +37.91%
May 5, 2025
Maintains: Neutral
Price Target: $80 → $68
Current: $78.93
Upside: -13.85%
May 2, 2025
Maintains: Buy
Price Target: $90 → $88
Current: $79.82
Upside: +10.25%
Apr 30, 2025
Upgrades: Buy
Price Target: $38 → $40
Current: $27.56
Upside: +45.14%
Apr 24, 2025
Upgrades: Buy
Price Target: $12 → $15
Current: $15.62
Upside: -3.97%
Jan 29, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $27.10
Upside: +10.70%
Oct 14, 2024
Initiates: Buy
Price Target: $38
Current: $21.56
Upside: +76.25%
Oct 9, 2024
Initiates: Buy
Price Target: $50
Current: $10.87
Upside: +359.98%
Aug 14, 2024
Maintains: Buy
Price Target: $247 → $267
Current: $186.26
Upside: +43.35%
Aug 11, 2023
Maintains: Outperform
Price Target: $450 → $485
Current: $693.45
Upside: -30.06%
Jul 31, 2023
Reiterates: Outperform
Price Target: $95
Current: $21.71
Upside: +337.59%
Jul 28, 2023
Maintains: Outperform
Price Target: $311 → $316
Current: $399.75
Upside: -20.95%
May 8, 2023
Maintains: Outperform
Price Target: $125 → $96
Current: $73.48
Upside: +30.65%
Feb 9, 2023
Maintains: Outperform
Price Target: $62 → $73
Current: $123.81
Upside: -41.04%
Feb 6, 2023
Maintains: Outperform
Price Target: $635 → $575
Current: $272.32
Upside: +111.15%
Jan 27, 2023
Upgrades: Neutral
Price Target: $38
Current: $26.38
Upside: +44.05%
Dec 7, 2022
Maintains: Outperform
Price Target: $590 → $610
Current: $339.78
Upside: +79.53%
Nov 23, 2022
Maintains: Outperform
Price Target: $308 → $305
Current: $274.09
Upside: +11.28%
Nov 22, 2022
Maintains: Neutral
Price Target: $64 → $79
Current: $148.37
Upside: -46.75%
Oct 27, 2022
Maintains: Outperform
Price Target: $350 → $410
Current: $176.45
Upside: +132.36%
Aug 4, 2022
Maintains: Neutral
Price Target: $43 → $37
Current: $4.96
Upside: +645.97%
Jul 22, 2022
Maintains: Neutral
Price Target: $158 → $143
Current: $180.16
Upside: -20.63%
Aug 6, 2021
Maintains: Outperform
Price Target: $300 → $270
Current: $294.21
Upside: -8.23%
Jan 25, 2021
Downgrades: Underperform
Price Target: $0.57
Current: $28.60
Upside: -98.01%